<?xml version="1.0" encoding="UTF-8"?>
<p>This study is a multicenter, randomized, double-blind, placebo-controlled trial conducted at six tertiary hospitals in China. The leading site is The First Affiliated Hospital of Soochow University, and the participating sites are Zhongshan Hospital Fudan University, Fudan University Shanghai Cancer Center, Shanghai General Hospital, The First Affiliated Hospital of Zhengzhou University, and The First Affiliated Hospital of Anhui Medical University.</p>
